1Alonso-Valle H,Acha O,Garcia-Palomo J D,et al.Candidemia in a tertiary care hospital:epidemiology and factors influencing mortality.Eur J Clin Microbiol Infect Dis,2003,22(4):254
2Vaideeswar P,Prasad S,Deshpande JR,et al.Invasive pulmonary aspergillosis:A study of 39 cases at autopsy.Journal of Postgraduate Medicine,2004,50 (1):21
3Cornelia L F,Eberhard G,Gunther G,et al.Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.Journal of Clinical Microbiology,2004,42(9):4154
4Lass-Florl C,Gunsilius E,Gastl G,et al.Clinical evaluation of aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients.Mycoses.2005,48(S):12
5Chen Y C,Ko S C,Hsueh P R,et al.Pulmonary fungal infection:emphasis on microbiological spectra,patient,outcome,and prognostic factors.Chest,2001,120:177
6Liaw Y S,Yang P C,Yu C J,et al.Direct determination of cryptococcal antigen in transthoracic needle aspirate for diagnosis of pulmonary cryptococcosis.J Clin Microbiol 1995,33:1588
9Hoffer FA,Gow K,Flynn PM,et al.Accuracy of percutaneous lung biopsy for invasive pulmonary aspergillosis.Pediatr Radiol,2001,31(3):144
10Glasmacher A,Cornely O A,Orlopp K,Reuter,et al.Caspofungin treatment in severely ill,immunocompromised patients:a case-documentation study of 118 patients.Antimicrob Chemother,2006,57(1):127
3Jarvis WR . Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis, 1995,20:1526-1530.
4Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis, 1999,29:1164-1170.
5Verduyn Lunel FM, Meis JF, Voss A, et al. Nosocomial fungal infections:candidemia. Diagn Microbiol Infect Dis, 1999,34:213-220.
6Edmond MB, Wallace SE, McClish DK,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis, 1999,29: 239-244.
7Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990.National Nosocomail Infections Surveillance System . J Infect Dis, 1993, 167:1247-1251.
8Haddad NE, Powderly WG. The changing face of mycoses in patients with HIV/AIDS. AIDS Read, 2001,11: 375-378.
9Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis, 1995,21:994-996.
10Pfalller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis, 1999,33:217-222.
